Niacin ameliorates ulcerative colitis via prostaglandin D2‐mediated D prostanoid receptor 1 activation
…, Q Zhang, Y Yu, Y Qian, S Zuo, G Liu, Q Liu… - EMBO Molecular …, 2017 - embopress.org
Niacin, as an antidyslipidemic drug, elicits a strong flushing response by release of prostaglandin
(PG) D 2 . However, whether niacin is beneficial for inflammatory bowel disease (IBD) …
(PG) D 2 . However, whether niacin is beneficial for inflammatory bowel disease (IBD) …
High COX‐2 expression in cancer‐associated fibiroblasts contributes to poor survival and promotes migration and invasiveness in nasopharyngeal carcinoma
Y Zhu, C Shi, L Zeng, G Liu, W Jiang… - Molecular …, 2020 - Wiley Online Library
Nasopharyngeal carcinoma (NPC) has the highest rate of metastasis among head and neck
cancers, and distant metastasis is the major reason for treatment failure. We have …
cancers, and distant metastasis is the major reason for treatment failure. We have …
PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation
D Kong, Y Shen, G Liu, S Zuo, Y Ji, A Lu… - Journal of experimental …, 2016 - rupress.org
The kinetic participation of macrophages is critical for inflammatory resolution and recovery
from myocardial infarction (MI), particularly with respect to the transition from the M1 to the …
from myocardial infarction (MI), particularly with respect to the transition from the M1 to the …
Loss of DP1 aggravates vascular remodeling in pulmonary arterial hypertension via mTORC1 signaling
…, C Zuo, D Jia, P Bai, D Kong, D Chen, G Liu… - American journal of …, 2020 - atsjournals.org
Rationale: Vascular remodeling, including smooth muscle cell hypertrophy and proliferation,
is the key pathological feature of pulmonary arterial hypertension (PAH). Prostaglandin I 2 …
is the key pathological feature of pulmonary arterial hypertension (PAH). Prostaglandin I 2 …
Inhibition of CRTH2-mediated Th2 activation attenuates pulmonary hypertension in mice
…, S Zuo, J Tang, C Zuo, D Jia, Q Liu, G Liu… - Journal of Experimental …, 2018 - rupress.org
Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by progressive
pulmonary artery (PA) remodeling. T helper 2 cell (Th2) immune response is involved …
pulmonary artery (PA) remodeling. T helper 2 cell (Th2) immune response is involved …
Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice
G Liu, Q Liu, Y Shen, D Kong, Y Gong… - British Journal of …, 2018 - Wiley Online Library
Background and Purpose An appropriate inflammatory response is necessary for cardiac
healing after acute myocardial infarction (MI). Resolvin E1 (RvE1) is an anti‐inflammatory and …
healing after acute myocardial infarction (MI). Resolvin E1 (RvE1) is an anti‐inflammatory and …
Resolvin E1 attenuates pulmonary hypertension by suppressing Wnt7a/β-catenin signaling
G Liu, N Wan, Q Liu, Y Chen, H Cui, Y Wang, J Ren… - …, 2021 - Am Heart Assoc
Pulmonary arterial hypertension (PAH) is a devastating disease characterized by severe
pulmonary vascular wall remodeling and perivascular inflammation. Resolvin E1 (RvE1), a …
pulmonary vascular wall remodeling and perivascular inflammation. Resolvin E1 (RvE1), a …
Resolvin E1 attenuates inj ury‐induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration
Mechanical insults, such as stent implantation, can induce endothelial injury, vascular
inflammation, and ultimately lead to vascular neointimal hyperplasia. Resolvin E1 (RvE1), derived …
inflammation, and ultimately lead to vascular neointimal hyperplasia. Resolvin E1 (RvE1), derived …
[HTML][HTML] Activation of E-prostanoid 3 receptor in macrophages facilitates cardiac healing after myocardial infarction
…, G Chen, Q Wan, K Wang, J Zhang, J Qin, G Liu… - Nature …, 2017 - nature.com
Two distinct monocyte (Mo)/macrophage (Mp) subsets (Ly6C low and Ly6C high ) orchestrate
cardiac recovery process following myocardial infarction (MI). Prostaglandin (PG) E 2 is …
cardiac recovery process following myocardial infarction (MI). Prostaglandin (PG) E 2 is …
[HTML][HTML] High COX-2 expression contributes to a poor prognosis through the inhibition of chemotherapy-induced senescence in nasopharyngeal carcinoma
…, G Liu, Y Zhu, H Xu, Y Lu, J Liu… - International …, 2018 - spandidos-publications.com
Resistance to radiotherapy and chemotherapy currently represents one of the major reasons
for therapeutic failure in nasopharyngeal carcinoma (NPC). However, the mechanisms …
for therapeutic failure in nasopharyngeal carcinoma (NPC). However, the mechanisms …